Maternal preeclampsia predicts the development of bronchopulmonary dysplasia.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Jornal de Pediatria

• Publication date

  2010-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jpeds.2009.10.018PMID 20004912
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Mechanisms of Preeclampsia

  2012cited by this paper
• Inhaled Nitric Oxide in Preterm Infants: A Systematic Review

  2011cited by this paper
• Endostatin Concentration in Cord Plasma Predicts the Development of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants

  2009cited by this paper
• Inhaled nitric oxide in the neonate

  2009cited by this paper
• Increased expression of placenta growth factor in COPD

  2008cited by this paper
• Antenatal inflammation and lung injury: prenatal origin of neonatal disease

  2008cited by this paper
• Molecular mechanisms of preeclampsia.

  2008cited by this paper
• Bronchopulmonary Dysplasia: A Genetic Disease

  2008cited by this paper
• Pregnancy outcomes in women with chronic hypertension: a population-based study.

  2007cited by this paper
• Inhaled Nitric Oxide for Preterm Infants: A Systematic Review

  2007cited by this paper
• Inhaled nitric oxide in the premature newborn.

  2007cited by this paper
• Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

  2006cited by this paper
• Soluble endoglin contributes to the pathogenesis of preeclampsia

  2006cited by this paper
• Circulating Angiogenic Factors and the Risk of Preeclampsia

  2005cited by this paper
• 171 RECOMBINANT HUMAN VEGF TREATMENT ENHANCES ALVEOLARIZATION AFTER HYPEROXIC LUNG INJURY IN NEONATAL RATS

  2005cited by this paper
• Inhaled nitric oxide for preterm infants--who benefits?

  2005cited by this paper
• Excess Soluble fms-Like Tyrosine Kinase 1 and Low Platelet Counts in Premature Neonates of Preeclamptic Mothers

  2005influential reference
• Vascular Endothelial Growth Factor Gene Therapy Increases Survival, Promotes Lung Angiogenesis, and Prevents Alveolar Damage in Hyperoxia-Induced Lung Injury: Evidence That Angiogenesis Participates in Alveolarization

  2005cited by this paper
• Comparison between HELLP syndrome, chronic hypertension, and superimposed preeclampsia on chronic hypertension without HELLP syndrome

  2004cited by this paper
• Placenta growth factor elevation in the cord blood of premature neonates predicts poor pulmonary outcome.

  2004cited by this paper
• Circulating angiogenic factors and the risk of preeclampsia.

  2004cited by this paper
• Neonatal Outcome in Pregnancies after Preterm Delivery for HELLP Syndrome

  2004cited by this paper
• Overexpression of placenta growth factor contributes to the pathogenesis of pulmonary emphysema.

  2004cited by this paper
• Maternal Hypertensive Disorders Are an Independent Risk Factor for the Development of Necrotizing Enterocolitis in Very Low Birth Weight Infants

  2003cited by this paper
• Second‐Trimester Maternal Serum Placental Growth Factor and Vascular Endothelial Growth Factor for Predicting Severe, Early‐Onset Preeclampsia

  2003cited by this paper
• Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia.

  2003cited by this paper
• Placental and Other Perinatal Risk Factors for Chronic Lung Disease in Very Low Birth Weight Infants

  2002cited by this paper
• Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema.

  2001cited by this paper
• Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

  2001cited by this paper
• Risk Factors in Retinopathy of Prematurity

  2000cited by this paper
• Preterm delivery for maternal or fetal indications: maternal morbidity, neonatal outcome and late sequelae in infants

  2000cited by this paper
• Inhibition of angiogenesis decreases alveolarization in the developing rat lung.

  2000cited by this paper
• Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia.

  2000cited by this paper
• Inhibition of VEGF receptors causes lung cell apoptosis and emphysema.

  2000cited by this paper
• Frequency and risk factors in bronchopulmonary dysplasia in a cohort of very low birth weight infants.

  1999cited by this paper
• Vascular endothelial growth factor in human preterm lung.

  1999cited by this paper
• Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity.

  1999cited by this paper
• Neonatal outcome in small for gestational age infants: Do they really better?

  1999cited by this paper
• Effect of preeclampsia on mortality, intraventricular hemorrhage, and need for mechanical ventilation in very low-birth-weight infants.

  1998cited by this paper
• Risk factors in retinopathy of prematurity

  1997cited by this paper
• Neonatal outcome after preterm delivery for preeclampsia.

  1996cited by this paper
• Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR.

  1996cited by this paper
• [Fetal development in mild and severe pre-eclampsia: correlation with maternal laboratory parameters and Doppler ultrasound].

  1995cited by this paper
• Learning SAS : a computer handbook for econometrics : a guide to programming for Griffiths/Hill/Judge, Learning and practicing econometrics, and Judge/Hill/Lütkepohl/Lee, Introduction to the theory and practice of econometrics, Second edition

  1993cited by this paper
• Maternal and fetal infections

  1992cited by this paper
• Maternal-fetal medicine: Principles and practice

  1984cited by this paper
• The Theory and Practice of Econometrics

  1981cited by this paper
• An improper use of statistical significance testing in studying covariables.

  1978cited by this paper
• American Journal of Epidemiology Original Contribution Pregnancy Disorders That Lead to Delivery before the 28th Week of Gestation: an Epidemiologic Approach to Classification

  year unknowncited by this paper

• Maternal Neutrophil Inflammation Markers Predict Bronchopulmonary Dysplasia in Preeclamptic Pregnancies

  2025cites this paper
• Severe maternal morbidity and risk of adverse pregnancy, delivery, and neonatal outcomes in the subsequent delivery.

  2025cites this paper
• Intraamniotic Vitamin D Preserves Lung Development and Prevents Pulmonary Hypertension in Experimental Bronchopulmonary Dysplasia due to Intraamniotic sFlt-1.

  2025cites this paper
• Ultrasound evaluation of persistent pulmonary hypertension of the newborn

  2025cites this paper
• Immune imbalance mediates the relationship between plasma vitamin D concentration and preeclampsia in Chinese pregnant women: a case–control study

  2025cites this paper
• Pattern of Independent Factors Influencing Preterm Infants' Chance of Survival to Discharge Without Any Significant Morbidities

  2025cites this paper
• Ischemic placental disease as a risk factor for bronchopulmonary dysplasia in extremely preterm infants

  2025influential citation
• Translation of mechanistic advances in preeclampsia to the clinic: Long and winding road

  2024cites this paper
• Mesenchymal stromal cell extracellular vesicles improve lung development in mechanically ventilated preterm lambs.

  2024cites this paper
• Amomum villosum Lour. alleviates pre-eclampsia by inducing enrichment of Bifidobacterium bifidum through vanillic acid to inhibit placental ferroptosis.

  2024cites this paper
• The Factors Associated With Continuous Positive Airway Pressure (CPAP) Failure in Late Preterm and Term Infants and Its Impact on In-Hospital Outcomes

  2024cites this paper
• Association between Antenatal Antibiotic Exposure and Bronchopulmonary Dysplasia: A Systematic Review and Bayesian Model-Averaged Meta-Analysis

  2024cites this paper
• Risk of Adverse Neonatal Events in Pregnancies Complicated by Severe Maternal Morbidity.

  2024cites this paper
• The relationship between severe hypertensive diseases of pregnancy and moderate-severe bronchopulmonary dysplasia

  2024cites this paper
• Pulmonary Hypertension in Established Bronchopulmonary Dysplasia: Physiologic Approaches to Clinical Care.

  2024cites this paper
• Immune Changes in Infants of Preeclampsia Mothers: A Systematic Review of Literature

  2023cites this paper
• Perinatal origins of bronchopulmonary dysplasia—deciphering normal and impaired lung development cell by cell

  2023cites this paper
• Erratum: Perinatal Hypoxia-Inducible Factor Stabilization Preserves Lung Alveolar and Vascular Growth in Experimental Bronchopulmonary Dysplasia

  2023cites this paper
• The programmed cell death protein 1 (PD1) and the programmed cell death ligand 1 (PD-L1) are significantly downregulated on macrophages and Hofbauer cells in the placenta of preeclampsia patients.

  2023cites this paper
• The Relationship Between Severe Hypertensive Diseases of Pregnancy and Moderate-Severe Bronchopulmonary Dysplasia

  2023cites this paper
• Recent Advances in Pediatric Pulmonary Hypertension: Implications for Diagnosis and Treatment.

  2023cites this paper
• Early Fetal Growth Restriction with or Without Hypertensive Disorders: a Clinical Overview

  2023cites this paper
• Pulmonary Vascular Phenotypes of Prematurity: The Path to Precision Medicine.

  2023cites this paper
• Mortality and morbidity of extremely low birth weight infants in Japan, 2015

  2023cites this paper
• The combined use of ultrasound examination of hemodynamics in the umbilical artery and urine microalbumin levels can predict adverse pregnancy outcomes in patients with severe preeclampsia

  2023cites this paper
• Mesenchymal stromal/stem cells and bronchopulmonary dysplasia

  2023cites this paper
• Global, Regional and National Trends in the Burden of Neonatal Respiratory Failure and essentials of its diagnosis and management from 1992 to 2022: a scoping review

  2023cites this paper
• Bronchopulmonary dysplasia – a new perspective on prevention and treatment

  2023cites this paper
• Neonatal outcomes of early preterm births according to the delivery indications.

  2023cites this paper
• The eNAMPT/TLR4 inflammatory cascade drives the severity of intra-amniotic inflammation in pregnancy and predicts infant outcomes

  2023cites this paper
• Adverse Neonatal Outcome of Pregnancies Complicated by Preeclampsia

  2022cites this paper
• The Global Pregnancy Collaboration (CoLab) symposium on short- and long-term outcomes in offspring whose mothers had preeclampsia: A scoping review of clinical evidence

  2022cites this paper
• Headway and the remaining hurdles of mesenchymal stem cells therapy for bronchopulmonary dysplasia

  2022cites this paper
• High Morbidity of Preterm Neonates in Pregnancy with Preeclampsia: A Retrospective Study in Indonesia

  2022cites this paper
• Human breast milk‐derived exosomes through inhibiting AT II cell apoptosis to prevent bronchopulmonary dysplasia in rat lung

  2022cites this paper
• Vascular Malperfusion – As a Morphological Pattern of Preeclampsia

  2022cites this paper
• Understanding the Role of Placental Pathophysiology in the Development of Bronchopulmonary Dysplasia (BPD).

  2022cites this paper
• Fetal growth restriction and neonatal-pediatric lung diseases: Vascular mechanistic links and therapeutic directions.

  2022cites this paper
• Maternal preeclampsia as a risk factor for developing bronchopulmonary dysplasia in neonates.

  2022cites this paper
• Placental Neutrophil Infiltration Associated with Tobacco Exposure but Not Development of Bronchopulmonary Dysplasia

  2022cites this paper
• Disparities in tracheostomies and gastrostomy tubes in infants at the edge of viability

  2022cites this paper
• Efectele preeclampsiei materne asupra nou-născutului – revizuire

  2022cites this paper
• Early Preeclampsia Effect on Preterm Newborns Outcome

  2022cites this paper
• Association of Maternal Hypertensive Disorders During Pregnancy With Severe Bronchopulmonary Dysplasia: A Systematic Review and Meta-Analysis

  2022cites this paper
• Preeclampsia at term can be classified into two clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood.

  2022cites this paper
• Antenatal Mesenchymal Stromal Cell Extracellular Vesicle Therapy Prevents Preeclamptic Lung Injury in Mice.

  2021cites this paper
• Association of the dysfunctional placentation endotype of prematurity with bronchopulmonary dysplasia: a systematic review, meta-analysis and meta-regression

  2021influential citation
• Respiratory problems in preterm infants with pulmonary hemorrhage

  2021cites this paper
• Evaluation of trends in Bronchopulmonary Dysplasia and Respiratory Support Practice for Very Low Birth Weight Infants: A Population-Based Cohort Study.

  2021cites this paper
• Maternal hypertension, pre-eclampsia, eclampsia and newborn hearing: A retrospective analysis of 454 newborns.

  2021cites this paper
• Pulmonary Hypertension: The Hidden Danger for Newborns

  2021cites this paper
• Early prediction of preeclampsia in pregnancy with circulating, cell-free RNA

  2021cites this paper
• Long‐term effects of preeclampsia on metabolic and biochemical outcomes in offspring: What can be expected from a meta‐analysis?

  2021cites this paper
• Untersuchung des Einflusses von Vitamin D3 auf die plazentare Angiogenese in vitro

  2021cites this paper
• A Retrospective Cohort Study on Mortality and Neurodevelopmental Outcomes of Preterm Very Low Birth Weight Infants Born to Mothers with Hypertensive Disorders of Pregnancy

  2021cites this paper
• Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease

  2021cites this paper
• Pulmonary hypertension in infants with bronchopulmonary dysplasia: risk factors, mortality and duration of hospitalisation

  2021cites this paper
• Antenatal Mesenchymal Stromal Cell Extracellular Vesicle Treatment Preserves Lung Development in a Model of Bronchopulmonary Dysplasia Due to Chorioamnionitis.

  2021cites this paper
• Pulmonary hypertension is an important co‐morbidity in developmental lung diseases of infancy: Bronchopulmonary dysplasia and congenital diaphragmatic hernia

  2021cites this paper
• Bronchopulmonary Dysplasia: Then, Now, and Next

  2020cites this paper
• Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders

  2020cites this paper
• Mesenchymal stromal cell-derived small extracellular vesicles restore lung architecture and improve exercise capacity in a model of neonatal hyperoxia-induced lung injury

  2020cites this paper
• Neonatal Outcome After Preeclampsia and HELLP Syndrome: A Population-Based Cohort Study in Germany

  2020cites this paper
• Perinatal Hypoxia-Inducible Factor Stabilization Preserves Lung Alveolar and Vascular Growth in Experimental BPD.

  2020cites this paper
• Nanoparticle-Mediated Simultaneous Downregulation of Placental Nrf2 and sFlt1 Improves Maternal and Fetal Outcomes in a Preeclampsia Mouse Model.

  2020cites this paper
• Tobacco Smoking During Pregnancy Is Associated With Increased Risk of Moderate/Severe Bronchopulmonary Dysplasia: A Systematic Review and Meta-Analysis

  2020cites this paper
• Perinatal risk factors of symptomatic preterm patent ductus arteriosus and secondary ligation.

  2020cites this paper
• Cholestasis after very preterm birth was associated with adverse neonatal outcomes but no significant long‐term liver disease: A population‐based study

  2020influential citation
• Fetal and neonatal complications of pregnancy induced hypertension

  2020cites this paper
• Preeclampsia was a risk factor for pulmonary interstitial emphysema in preterm infants born ≤32 weeks of gestational age

  2020cites this paper
• rhIGF-1/BP3 Preserves Lung Growth and Prevents Pulmonary Hypertension in Experimental Bronchopulmonary Dysplasia

  2020cites this paper
• The Human Breast Milk Metabolome in Preeclampsia, Gestational Diabetes, and Intrauterine Growth Restriction: Implications for Child Growth and Development.

  2020cites this paper
• In utero exposure to pre‐eclampsia as an independent risk factor for long‐term respiratory disease

  2020cites this paper
• Pediatric Pulmonary Hypertension and Relevant Experimental Animal Models: Pulmonary Arterial Hypertension, Bronchopulmonary Dysplasia and Congenital Diaphragmatic Hernia

  2019cites this paper
• Pre-eclampsia: pathogenesis, novel diagnostics and therapies

  2019cites this paper
• Preeclampsia: Pathophysiology, Challenges, and Perspectives

  2019cites this paper
• Preeclampsia.

  2019cites this paper
• Perinatal Events and Their Influence on Lung Development and Injury

  2019cites this paper
• Maternal preeclampsia and respiratory outcomes in extremely premature infants

  2019cites this paper
• Long non-coding RNA NR_002794 is upregulated in pre-eclampsia and regulates the proliferation, apoptosis and invasion of trophoblast cells

  2019cites this paper
• A Physiology-Based Approach to the Respiratory Care of Children With Severe Bronchopulmonary Dysplasia

  2019cites this paper
• Hypertensive disorders during pregnancy are associated with reduced severe intraventricular hemorrhage in very-low-birth-weight infants

  2019cites this paper
• Could circRNA be a new biomarker for pre‐eclampsia?

  2019cites this paper
• Length at birth z-score is inversely associated with an increased risk of bronchopulmonary dysplasia or death in preterm infants born before 32 gestational weeks: A nationwide cohort study

  2019cites this paper
• Association of Maternal Preeclampsia with Neonatal Respiratory Distress Syndrome in Very-Low-Birth-Weight Infants

  2019cites this paper
• Small for gestational age very preterm infants present a higher risk of developing bronchopulmonary dysplasia

  2019cites this paper
• Associations of Preeclampsia with Expiratory Airflows in School-Age Children Born Either at <28 Weeks or Weighing <1000 g.

  2019cites this paper
• How does preeclampsia affect neonates? Highlights in the disease’s immunity

  2019cites this paper
• Association of Chorioamnionitis With Bronchopulmonary Dysplasia Among Preterm Infants

  2019cites this paper
• Strategies to improve outcomes of bronchopulmonary dysplasia

  2019cites this paper
• Bronchopulmonary dysplasia

  2019cites this paper
• Preeclampsia and risk of developing bronchopulmonary dysplasia in very preterm neonates.

  2019cites this paper
• Vascular placental pathology and the relationship between hypertensive disorders of pregnancy and neonatal outcomes in very low birth weight infants

  2018cites this paper
• Anti-Vascular Endothelial Growth Factor Antagonists: A Potential Primary Prevention for Bronchopulmonary Dysplasia?

  2018cites this paper
• An sFlt-1:PlGF ratio of 655 is not a reliable cut-off value for predicting perinatal outcomes in women with preeclampsia.

  2018cites this paper
• Pregnancy-induced hypertension and neonatal outcomes: a systematic review and meta-analysis

  2018cites this paper
• Cystatin C as a novel predictor of preterm labor in severe preeclampsia

  2018cites this paper
• Association between Hypertensive Disorders during Pregnancy and Risk of BPD in Very Preterm Infants

  2018cites this paper
• Bronchopulmonary dysplasia: Pathogenesis and treatment.

  2018cites this paper
• Genetic Variants in Preeclampsia: Lessons From Studies in Latin-American Populations

  2018cites this paper